{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:06:21Z","timestamp":1793019981524,"version":"4.5.0"},"update-to":[{"DOI":"10.1371\/journal.pmed.1003856","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000}}],"reference-count":84,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The rise in the global prevalence of diabetes, particularly among younger people, has led to an increase in the number of pregnant women with preexisting diabetes, many of whom have diabetes-related microvascular complications. We aimed to estimate the magnitude of the risks of adverse pregnancy outcomes or disease progression in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>\n                      We undertook a systematic review and meta-analysis on maternal and perinatal complications in women with type 1 or 2 diabetic microvascular disease and the risk factors for worsening of microvascular disease in pregnancy using a prospective protocol (PROSPERO CRD42017076647). We searched major databases (January 1990 to July 2021) for relevant cohort studies. Study quality was assessed using the Newcastle\u2013Ottawa Scale. We summarized the findings as odds ratios (ORs) with 95% confidence intervals (CIs) using random effects meta-analysis. We included 56 cohort studies involving 12,819 pregnant women with diabetes; including 40 from Europe and 9 from North America. Pregnant women with diabetic nephropathy were at greater risk of preeclampsia (OR 10.76, CI 6.43 to 17.99,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001), early (&lt;34 weeks) (OR 6.90, 95% CI 3.38 to 14.06,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001) and any preterm birth (OR 4.48, CI 3.40 to 5.92,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001), and cesarean section (OR 3.04, CI 1.24 to 7.47,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.015); their babies were at higher risk of perinatal death (OR 2.26, CI 1.07 to 4.75,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.032), congenital abnormality (OR 2.71, CI 1.58 to 4.66,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001), small for gestational age (OR 16.89, CI 7.07 to 40.37,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001), and admission to neonatal unit (OR 2.59, CI 1.72 to 3.90,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001) compared to those without nephropathy. Diabetic retinopathy was associated with any preterm birth (OR 1.67, CI 1.27 to 2.20,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001) and preeclampsia (OR 2.20, CI 1.57 to 3.10,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001) but not other complications. The risks of onset or worsening of retinopathy were increased in women who were nulliparous (OR 1.75, 95% CI 1.28 to 2.40,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001), smokers (OR 2.31, 95% CI 1.25 to 4.27,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.008), with existing proliferative disease (OR 2.12, 95% CI 1.11 to 4.04,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.022), and longer duration of diabetes (weighted mean difference: 4.51 years, 95% CI 2.26 to 6.76,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001) compared to those without the risk factors. The main limitations of this analysis are the heterogeneity of definition of retinopathy and nephropathy and the inclusion of women both with type 1 and type 2 diabetes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In pregnant women with diabetes, presence of nephropathy and\/or retinopathy appear to further increase the risks of maternal complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pmed.1003856","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T13:34:46Z","timestamp":1637588086000},"page":"e1003856","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":50,"title":["Adverse pregnancy outcomes in women with diabetes-related microvascular disease and risks of disease progression in pregnancy: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2007-9647","authenticated-orcid":true,"given":"Sophie","family":"Relph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7862-9349","authenticated-orcid":true,"given":"Trusha","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2749-7665","authenticated-orcid":true,"given":"Louisa","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3020-0911","authenticated-orcid":true,"given":"Soha","family":"Sobhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4254-460X","authenticated-orcid":true,"given":"Shakila","family":"Thangaratinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"key":"pmed.1003856.ref001","unstructured":"World Health Organisation. Global Report on Diabetes. France; 2016."},{"issue":"9945","key":"pmed.1003856.ref002","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"M Ng","year":"2014","journal-title":"Lancet"},{"key":"pmed.1003856.ref003","unstructured":"NHS Digital. National Pregnancy in Diabetes (NPID) Audit Report 2018. 2019 [cited 2021 Jan 11]. Available from: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/national-pregnancy-in-diabetes-audit\/national-pregnancy-in-diabetes-annual-report-2018."},{"issue":"4","key":"pmed.1003856.ref004","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11892-015-0586-5","article-title":"Vascular Complications in the Diabetic Pregnancy","volume":"15","author":"G Leguizam\u00f3n","year":"2015","journal-title":"Curr Diab Rep"},{"issue":"11","key":"pmed.1003856.ref005","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.2337\/dc13-1031","article-title":"Diabetic nephropathy and microalbuminuria in pregnant women with type 1 and type 2 diabetes: prevalence, antihypertensive strategy, and pregnancy outcome","volume":"36","author":"JA Damm","year":"2013","journal-title":"Diabetes Care"},{"key":"pmed.1003856.ref006","unstructured":"Centers for Disease Control and Prevention. Common Eye Disorders and Diseases: Diabetic Retinopathy. 2020 [cited 2020 Jan 11]. Available from: https:\/\/www.cdc.gov\/visionhealth\/basics\/ced\/index.html#a5."},{"issue":"4","key":"pmed.1003856.ref007","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/ceo.12760","article-title":"Diabetic retinopathy in pregnancy: a review","volume":"44","author":"JL Morrison","year":"2016","journal-title":"Clin Exp Ophthalmol"},{"key":"pmed.1003856.ref008","author":"M Knight","year":"2019","journal-title":"Saving Lives, Improving Mothers\u2019 Care"},{"key":"pmed.1003856.ref009","unstructured":"National Institute for Health and Care Excellence. Diabetes in pregnancy: management from preconception to the postnatal period. 2015."},{"key":"pmed.1003856.ref010","author":"T Patel","year":"2017","journal-title":"Maternal and offspring outcomes in pregnant women with pre-existing diabetes complicated by nephropathy and retinopathy: a systematic review and meta-analysis"},{"key":"pmed.1003856.ref011","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"D Moher","year":"2009","journal-title":"BMJ"},{"key":"pmed.1003856.ref012","author":"G Wells","year":"2000","journal-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses"},{"issue":"7109","key":"pmed.1003856.ref013","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"M Egger","year":"1997","journal-title":"BMJ"},{"key":"pmed.1003856.ref014","unstructured":"StataCorp. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP; 2015."},{"issue":"5","key":"pmed.1003856.ref015","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0002-9343(49)90382-4","article-title":"Pregnancy complicating diabetes","volume":"7","author":"P White","year":"1949","journal-title":"Am J Med"},{"issue":"2","key":"pmed.1003856.ref016","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00400099","article-title":"Pregnancies in women with diabetic nephropathy: Long-term outcome for mother and child","volume":"38","author":"R Kimmerle","year":"1995","journal-title":"Diabetologia"},{"issue":"3","key":"pmed.1003856.ref017","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0029-7844(95)00420-3","article-title":"Perinatal outcome and long-term follow-up associated with modern management of diabetic nephropathy","volume":"87","author":"M Gordon","year":"1996","journal-title":"Obstet Gynecol"},{"issue":"4","key":"pmed.1003856.ref018","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0002-9378(96)70660-9","article-title":"Does pregnancy increase the risk for development and progression of diabetic nephropathy?","volume":"174","author":"M Miodovnik","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"pmed.1003856.ref019","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2337\/diacare.19.10.1067","article-title":"Effect of pregnancy on renal function in patients with moderate-to-severe diabetic renal insufficiency","volume":"19","author":"LP Purdy","year":"1996","journal-title":"Diabetes Care"},{"issue":"8","key":"pmed.1003856.ref020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/qjmed\/92.8.451","article-title":"Pregnancy outcome in women with insulin-dependent diabetes mellitus complicated by nephropathy","volume":"92","author":"FP Dunne","year":"1999","journal-title":"QJM"},{"issue":"5","key":"pmed.1003856.ref021","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1081\/JDI-100100898","article-title":"Perinatal complications and three-year follow up of infants of diabetic mothers with diabetic nephropathy stage IV","volume":"22","author":"G Biesenbach","year":"2000","journal-title":"Ren Fail"},{"issue":"10","key":"pmed.1003856.ref022","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2337\/diacare.24.10.1739","article-title":"Pregnancy outcome in type 1 diabetic women with microalbuminuria","volume":"24","author":"P Ekbom","year":"2001","journal-title":"Diabetes Care"},{"issue":"2","key":"pmed.1003856.ref023","first-page":"75","article-title":"Effect of pregnancy on diabetic nephropathy and retinopathy","volume":"14","author":"S Irfan","year":"2004","journal-title":"J Coll Physicians Surg Pak"},{"issue":"5","key":"pmed.1003856.ref024","first-page":"802","article-title":"Early-pregnancy proteinuria in diabetes related to preeclampsia","volume":"82","author":"CA Combs","year":"1993","journal-title":"Obstet Gynecol"},{"issue":"1","key":"pmed.1003856.ref025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00125-015-3787-1","article-title":"White\u2019s classification and pregnancy outcome in women with type 1 diabetes: a population-based cohort study","volume":"59","author":"MM Klemetti","year":"2016","journal-title":"Diabetologia"},{"issue":"11","key":"pmed.1003856.ref026","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1464-5491.2007.02254.x","article-title":"Associations of Type 1 diabetes mellitus, maternal vascular disease and complications of pregnancy","volume":"24","author":"C Howarth","year":"2007","journal-title":"Diabet Med"},{"issue":"1","key":"pmed.1003856.ref027","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2337\/dc08-1526","article-title":"Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy?","volume":"32","author":"LR Nielsen","year":"2009","journal-title":"Diabetes Care"},{"key":"pmed.1003856.ref028","first-page":"S485","volume":"54","author":"L Ringholm","year":"2011","journal-title":"Higher levels of Atrial Natriuretic Peptide (ANP) are present in early pregnancy in type 1 diabetic women developing preeclampsia, September 2011"},{"issue":"3","key":"pmed.1003856.ref029","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.dsx.2012.02.013","article-title":"Effects of pregnancy on the onset and progression of diabetic nephropathy and of diabetic nephropathy on pregnancy outcomes","volume":"5","author":"EC Young","year":"2011","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"pmed.1003856.ref030","first-page":"323","article-title":"Diabetic nephropathy in pregnant women with type 1 diabetes mellitus","volume":"34","author":"Y Themeli","year":"2012","journal-title":"G Ital Ostet Ginecol"},{"issue":"12","key":"pmed.1003856.ref031","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1034\/j.1600-0412.2001.801204.x","article-title":"Ambulatory blood pressure as predictor of preeclampsia in diabetic pregnancies with respect to urinary albumin excretion rate and glycemic regulation","volume":"80","author":"FF Lauszus","year":"2001","journal-title":"Acta Obstet Gynecol Scand"},{"key":"pmed.1003856.ref032","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.diabres.2018.02.014","article-title":"Diastolic blood pressure is a potentially modifiable risk factor for preeclampsia in women with pre-existing diabetes","volume":"138","author":"SK Norgaard","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"pmed.1003856.ref033","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1900\/RDS.2013.10.68","article-title":"Severe diabetic nephropathy in type 1 diabetes and pregnancy\u2014a case series","volume":"10","author":"GB Piccoli","year":"2013","journal-title":"Rev Diabet Stud"},{"issue":"9","key":"pmed.1003856.ref034","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3109\/14767050903544744","article-title":"Maternal overweight and pregnancy outcome in women with Type-1 diabetes mellitus and different degrees of nephropathy","volume":"23","author":"Y Yogev","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"pmed.1003856.ref035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00404-007-0541-z","article-title":"Spontaneous and indicated preterm delivery in pregestational diabetes mellitus: etiology and risk factors","volume":"278","author":"N Melamed","year":"2008","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"pmed.1003856.ref036","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/AOG.0b013e3181d992ab","article-title":"Factors associated with cesarean delivery in nulliparous women with type 1 diabetes","volume":"115","author":"J Lepercq","year":"2010","journal-title":"Obstet Gynecol"},{"key":"pmed.1003856.ref037","article-title":"Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study","author":"R Bell","year":"2012","journal-title":"Diabetologia"},{"key":"pmed.1003856.ref038","first-page":"266","article-title":"Pregnancy outcome of mothers with diabetic nephropathy","volume":"27","author":"M Herman","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"12","key":"pmed.1003856.ref039","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1007\/s001250051565","article-title":"Glycaemic control is associated with pre-eclampsia but not with pregnancy-induced hypertension in women with type I diabetes mellitus","volume":"43","author":"V Hiilesmaa","year":"2000","journal-title":"Diabetologia"},{"issue":"6","key":"pmed.1003856.ref040","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1034\/j.1600-0412.1998.770608.x","article-title":"Epidemiology of pregnancy-induced hypertension and preeclampsia in type 1 (insulin-dependent) diabetic pregnancies in Sweden","volume":"77","author":"U Hanson","year":"1998","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"pmed.1003856.ref041","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.preghy.2013.09.001","article-title":"The risk of preeclampsia beyond the first pregnancy among women with type 1 diabetes parity and preeclampsia in type 1 diabetes","volume":"4","author":"MT Castiglioni","year":"2014","journal-title":"Pregnancy Hypertens"},{"issue":"2","key":"pmed.1003856.ref042","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1442-200X.1991.tb01536.x","article-title":"Perinatal morbidity of infants of diabetic mothers","volume":"33","author":"J Hoshi","year":"1991","journal-title":"Acta Paediatr Jpn"},{"issue":"6","key":"pmed.1003856.ref043","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1447-0756.1997.tb00886.x","article-title":"Statistical analysis of perinatal outcomes in pregnancy complicated with diabetes mellitus","volume":"23","author":"L Zhu","year":"1997","journal-title":"J Obstet Gynaecol Res"},{"key":"pmed.1003856.ref044","first-page":"58","article-title":"In type 1 diabetic women retinopathy and nephropathy are predictors of caesarean delivery independently of glucose control","author":"A Dodesini","year":"2009","journal-title":"Diabetes"},{"key":"pmed.1003856.ref045","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/archdischild-2013-303966.307","article-title":"Micro-vascular disease at booking in T1DM and associated risk of developing pre-eclampsia","volume":"98","author":"N Patel","year":"2013","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"pmed.1003856.ref046","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0002-9378(90)91184-E","article-title":"Preeclampsia in diabetic pregnancies","volume":"163","author":"PR Garner","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"pmed.1003856.ref047","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.06.066","article-title":"The association of intrauterine growth abnormalities in women with type 1 diabetes mellitus complicated by vasculopathy","volume":"199","author":"S Haeri","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"pmed.1003856.ref048","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1471-0528.2006.01071.x","article-title":"Glycaemic control throughout pregnancy and risk of pre-eclampsia in women with type I diabetes","volume":"113","author":"RC Temple","year":"2006","journal-title":"BJOG"},{"issue":"2","key":"pmed.1003856.ref049","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/dme.13872","article-title":"The association between vascular complications during pregnancy in women with Type 1 diabetes and congenital malformations","volume":"36","author":"L Samii","year":"2019","journal-title":"Diabet Med"},{"issue":"1","key":"pmed.1003856.ref050","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4149\/BLL_2017_011","article-title":"Pregnancy and neonatal outcomes in women with type 1 diabetes mellitus","volume":"118","author":"L Durackova","year":"2017","journal-title":"Bratisl Med J"},{"key":"pmed.1003856.ref051","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00592-017-1053-3","article-title":"Determinants of preeclampsia in women with type 1 diabetes","volume":"54","author":"P Gutaj","year":"2017","journal-title":"Acta Diabetol"},{"issue":"2","key":"pmed.1003856.ref052","first-page":"58","article-title":"Neonatal morbidity in infants of diabetic mothers","volume":"194","author":"A Schoetzau","year":"1990","journal-title":"Z Geburtshilfe Perinatol"},{"issue":"5","key":"pmed.1003856.ref053","first-page":"275","article-title":"Diabetic retinopathy and nephropathy\u2014Complications during pregnancy and delivery","volume":"55","author":"H Hopp","year":"1995","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"5","key":"pmed.1003856.ref054","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2337\/diacare.18.5.631","article-title":"Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study","volume":"18","author":"EY Chew","year":"1995","journal-title":"Diabetes Care"},{"issue":"4","key":"pmed.1003856.ref055","first-page":"587","article-title":"Fetal weight and progression of diabetic retinopathy","volume":"97","author":"SS McElvy","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"1","key":"pmed.1003856.ref056","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2337\/dc20-0904","article-title":"Progression of Diabetic Retinopathy and Predictors of Its Development and Progression During Pregnancy in Patients With Type 1 Diabetes: A Report of 499 Pregnancies","volume":"44","author":"J Bourry","year":"2021","journal-title":"Diabetes Care"},{"issue":"1","key":"pmed.1003856.ref057","first-page":"41","article-title":"How pregnancy influences renal function in nephropathic type 1 diabetic women depends on their pre-conceptional creatinine clearance","volume":"12","author":"G Biesenbach","year":"1999","journal-title":"J Nephrol Nurs"},{"issue":"7","key":"pmed.1003856.ref058","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1464-5491.2001.00535.x","article-title":"Impact of pregnancy on the progression of diabetic retinopathy in Type 1 diabetes","volume":"18","author":"RC Temple","year":"2001","journal-title":"Diabet Med"},{"issue":"2","key":"pmed.1003856.ref059","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1167\/iovs.04-0604","article-title":"Retinal artery and vein diameters during pregnancy in diabetic women","volume":"46","author":"M Larsen","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"pmed.1003856.ref060","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s00125-010-1697-9","article-title":"Progression of diabetic retinopathy during pregnancy in women with type 2 diabetes","volume":"53","author":"KL Rasmussen","year":"2010","journal-title":"Diabetologia"},{"issue":"8\u20139","key":"pmed.1003856.ref061","first-page":"474","article-title":"Progressive aspects of diabetic retinopathy during pregnancy","volume":"15","author":"S Ayed","year":"1992","journal-title":"J Fr Ophtalmol"},{"issue":"4","key":"pmed.1003856.ref062","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0002-9378(11)90608-5","article-title":"Progression of diabetic retinopathy in pregnancy: association with hypertension in pregnancy","volume":"166","author":"B Rosenn","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"pmed.1003856.ref063","first-page":"310239","article-title":"Diabetic retinopathy in pregnancy: a population-based study of women with pregestational diabetes","volume":"2015","author":"AM Egan","year":"2015","journal-title":"J Diabetes Res"},{"issue":"11","key":"pmed.1003856.ref064","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0161-6420(96)30421-1","article-title":"Diabetic retinopathy during pregnancy","volume":"103","author":"R Axer-Siegel","year":"1996","journal-title":"Ophthalmology"},{"issue":"6","key":"pmed.1003856.ref065","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00125-008-0994-z","article-title":"Influence of pregnancy on long-term progression of retinopathy in patients with type 1 diabetes","volume":"51","author":"CS Arun","year":"2008","journal-title":"Diabetologia"},{"issue":"6","key":"pmed.1003856.ref066","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s10384-016-0464-y","article-title":"The effect of pregnancy on the progression of diabetic retinopathy","volume":"60","author":"J Toda","year":"2016","journal-title":"Jpn J Ophthalmol"},{"issue":"4","key":"pmed.1003856.ref067","first-page":"163","article-title":"Effect of pregnancy on diabetic retinopathy","volume":"23","author":"J Maayah","year":"2001","journal-title":"Bahrain Medical Bull"},{"issue":"12","key":"pmed.1003856.ref068","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/(SICI)1096-9136(199712)14:12<1059::AID-DIA505>3.0.CO;2-8","article-title":"Pre-eclampsia is a potent risk factor for deterioration of retinopathy during pregnancy in Type 1 diabetic patients","volume":"14","author":"M Lovestam-Adrian","year":"1997","journal-title":"Diabet Med"},{"issue":"3","key":"pmed.1003856.ref069","doi-asserted-by":"crossref","first-page":"852","DOI":"10.2337\/diabetes.52.3.852","article-title":"Increased serum IGF-I during pregnancy is associated with progression of diabetic retinopathy","volume":"52","author":"F Lauszus","year":"2003","journal-title":"Diabetes"},{"issue":"3","key":"pmed.1003856.ref070","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1442-9071.2006.01413.x","article-title":"Progression of retinopathy during pregnancy in type 1 diabetes mellitus","volume":"35","author":"W Rahman","year":"2007","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"pmed.1003856.ref071","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ghir.2010.12.001","article-title":"Pregnancy-induced increase in circulating IGF-I is associated with progression of diabetic retinopathy in women with type 1 diabetes","volume":"21","author":"L Ringholm","year":"2011","journal-title":"Growth Hormon IGF Res"},{"issue":"8","key":"pmed.1003856.ref072","first-page":"3199","article-title":"Retinal blood flow changes during pregnancy in women with diabetes","volume":"35","author":"HC Chen","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"pmed.1003856.ref073","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-2007-993968","article-title":"Pregnancy performance and outcomes associated with diabetic nephropathy","volume":"15","author":"EA Reece","year":"1998","journal-title":"Am J Perinatol"},{"issue":"6","key":"pmed.1003856.ref074","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1111\/ajo.13265","article-title":"ADIPS 2020 guideline for pre-existing diabetes and pregnancy","volume":"60","author":"VL Rudland","year":"2020","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"pmed.1003856.ref075","unstructured":"ACOG Guidance on Perinatal Management of Pregestational Diabetes [cited 2021 Mar 14]. Available from: https:\/\/www.obgproject.com\/2018\/12\/18\/updated-acog-guidance-on-perinatal-management-of-pregestational-diabetes\/."},{"key":"pmed.1003856.ref076","unstructured":"Confidential Enquiry into Maternal and Child Health. Diabetes in Pregnancy: Are we providing the best care? Findings of a National Enquiry: England, Wales and Northern Ireland. London. 2007 [cited 2021 Feb 28]. Available from: https:\/\/www.publichealth.hscni.net\/sites\/default\/files\/Diabetes%20in%20Pregnancy-%20are%20we%20providing%20the%20best%20care.pdf."},{"issue":"1","key":"pmed.1003856.ref077","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2337\/diacare.13.1.34","article-title":"Effect of pregnancy on progression of diabetic retinopathy","volume":"13","author":"B Klein","year":"1990","journal-title":"Diabetes Care"},{"issue":"5","key":"pmed.1003856.ref078","first-page":"170","article-title":"Follow-up of albumin excretion during pregnancy and post partum in type 1 diabetic patients in comparison with health pregnant probands","volume":"24","author":"J Diglas","year":"1997","journal-title":"Acta Med Austriaca"},{"issue":"5","key":"pmed.1003856.ref079","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.amjhyper.2005.12.010","article-title":"Diabetic nephropathy in pregnancy: suboptimal hypertensive control associated with preterm delivery","volume":"19","author":"DB Carr","year":"2006","journal-title":"Am J Hypertens"},{"issue":"7","key":"pmed.1003856.ref080","first-page":"481","article-title":"Progression of diabetic retinopathy during pregnancy: a retrospective analysis of a series of 77 consecutive patients","volume":"33","author":"L Stalnikiewicz","year":"2010","journal-title":"J Fr Ophtalmol"},{"issue":"8","key":"pmed.1003856.ref081","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2337\/diacare.23.8.1084","article-title":"Effect of pregnancy on microvascular complications in the diabetes control and complications trial","volume":"23","author":"The Diabetes Control and Complications Trial Research Group","year":"2000","journal-title":"Diabetes Care"},{"issue":"7","key":"pmed.1003856.ref082","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia","volume":"377","author":"DL Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"pmed.1003856.ref083","article-title":"Maternity services in the UK during the coronavirus disease 2019 pandemic: a national survey of modifications to standard care","author":"J Jardine","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"pmed.1003856.ref084","unstructured":"National Perinatal Epidemiology Unit. UK Obstetric Surveillance System. 2018 [cited 2018 Sept 6]. Available from: https:\/\/www.npeu.ox.ac.uk\/ukoss."}],"updated-by":[{"DOI":"10.1371\/journal.pmed.1003856","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000}}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003856","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T18:54:12Z","timestamp":1699815252000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003856"}},"subtitle":[],"editor":[{"given":"Jenny E.","family":"Myers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":84,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1003856","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,22]]}}}